Paeds SAQs · nephrology-urology-fluids-and-electrolytes
Nocturnal enuresis — formative SAQs
Two formative SAQs on paediatric nocturnal enuresis: the school-age child with monosymptomatic bedwetting (assessment, classification and first-line therapy with alarm or desmopressin), and the child with new polyuria, polydipsia and weight loss or daytime symptoms (red flags and the divergence of the pathway).
On this page
Study tools
Target exams
SAQ 1 — The school-age child who wets the bed (20 marks, ~15 minutes)
A 7-year-old boy wets the bed on five or six nights a week. He is dry by day, growing normally and otherwise well. His father wet the bed until age 11. A voiding diary shows a large overnight urine volume with normal daytime voids, and urinalysis is normal. The family is motivated and able to wake with the child but would also like the option of quick control for an upcoming school camp. [1]
Questions
- Define nocturnal enuresis and classify this child's presentation. (5 marks) [1]
- Outline the focused assessment and the role of investigations, stating what is not routinely needed. (5 marks) [1] [3]
- Compare the enuresis alarm and desmopressin as first-line therapy, and recommend a plan for this child. (6 marks) [4] [5]
- State the desmopressin dose and the single most important safety measure. (4 marks) [4] [8]
Model answer (must-hit)
- Nocturnal enuresis is intermittent involuntary voiding during sleep in a child aged five years or older. This child has monosymptomatic nocturnal enuresis (bedwetting with no daytime symptoms), which is primary (he has never been dry for six months), with nocturnal polyuria on the diary and a strongly positive family history consistent with autosomal dominant inheritance (about a 44 per cent risk with one affected parent). [1]
- The assessment is a structured voiding and fluid diary, a focused examination of the abdomen, genitalia, spine and lower limbs, and urinalysis. The diary confirms the large overnight urine volume and normal daytime voids. Ultrasound, urodynamics and further imaging are not routine in monosymptomatic enuresis with a normal examination and urinalysis; they are reserved for non-monosymptomatic disease, recurrent infection, abnormal examination or treatment failure. [1] [3]
- The alarm conditions arousal by pairing the first drops of urine with waking and gives the most durable dryness, with about two-thirds of committed children becoming dry, but it takes weeks and demands a committed family. Desmopressin has a rapid effect, targets nocturnal polyuria directly, and is ideal for short-term control such as a school camp, but relapses on withdrawal. For this motivated family with nocturnal polyuria and an upcoming camp, desmopressin is started for the rapid control, with the alarm offered in parallel or afterwards for durable dryness; the partial responder moves to combination therapy. [4] [5]
- Desmopressin is given as 200 micrograms orally at bedtime, titrated to 400 micrograms if needed, or 120 to 360 micrograms sublingually. The single most important safety measure is to restrict fluids from one hour before the dose until eight hours after, and to withhold it during vomiting, diarrhoea or systemic illness, to prevent water intoxication and hyponatraemic seizures. [4] [8]
References6ShowHide
- [1]Nevéus T; Fonseca E; Franco I; et al Management and treatment of nocturnal enuresis-an updated standardization document from the International Children's Continence Society. J Pediatr Urol, 2020.PMID 32278657
- [3]Kuwertz-Bröking E; von Gontard A Clinical management of nocturnal enuresis. Pediatr Nephrol, 2018.PMID 28828529
- [4]Hahn D; Stewart F; Raman G Desmopressin for nocturnal enuresis in children. Cochrane Database Syst Rev, 2025.PMID 40728007
- [5]Glazener CM; Evans JH; Peto RE Alarm interventions for nocturnal enuresis in children. Cochrane Database Syst Rev, 2005.PMID 15846643
- [8]Skoog SJ; Stokes A; Turner KL Oral desmopressin: a randomized double-blind placebo controlled study of effectiveness in children with primary nocturnal enuresis. J Urol, 1997.PMID 9258137
- [11]Chen X; Zeng F; Tian N; et al Efficacy and safety of first-line therapies and first-line-based combination therapies for monosymptomatic nocturnal enuresis in children: a network meta-analysis. Pediatr Nephrol, 2026.PMID 41902910